The stable traits of melanoma genetics: an alternate approach to target discovery
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The stable traits of melanoma genetics: an alternate approach to target discovery ; volume:13 ; number:1 ; day:26 ; month:4 ; year:2012 ; pages:1-11 ; date:12.2012
BMC genomics ; 13, Heft 1 (26.4.2012), 1-11, 12.2012
- Creator
-
Spivey, Tara L.
- Contributor
-
De Giorgi, Valeria
Zhao, Yingdong
Bedognetti, Davide
Pos, Zoltan
Liu, Qiuzhen
Tomei, Sara
Ascierto, Maria Libera
Uccellini, Lorenzo
Reinboth, Jennifer
Chouchane, Lotfi
Stroncek, David F.
Wang, Ena
Marincola, Francesco M.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-13-156
- URN
-
urn:nbn:de:1111-2016072837950
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spivey, Tara L.
- De Giorgi, Valeria
- Zhao, Yingdong
- Bedognetti, Davide
- Pos, Zoltan
- Liu, Qiuzhen
- Tomei, Sara
- Ascierto, Maria Libera
- Uccellini, Lorenzo
- Reinboth, Jennifer
- Chouchane, Lotfi
- Stroncek, David F.
- Wang, Ena
- Marincola, Francesco M.
- SpringerLink (Online service)
Other Objects (12)
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
Melanoma-restricted genes
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
Melanoma-restricted genes
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation